213 related articles for article (PubMed ID: 20302565)
1. Potential role of acrolein in neurodegeneration and in Alzheimer's disease.
Dang TN; Arseneault M; Murthy V; Ramassamy C
Curr Mol Pharmacol; 2010 Jun; 3(2):66-78. PubMed ID: 20302565
[TBL] [Abstract][Full Text] [Related]
2. Role of by-products of lipid oxidation in Alzheimer's disease brain: a focus on acrolein.
Singh M; Dang TN; Arseneault M; Ramassamy C
J Alzheimers Dis; 2010; 21(3):741-56. PubMed ID: 20634576
[TBL] [Abstract][Full Text] [Related]
3. Modulation of hydrogen peroxide and acrolein-induced oxidative stress, mitochondrial dysfunctions and redox regulated pathways by the Bacopa monniera extract: potential implication in Alzheimer's disease.
Singh M; Murthy V; Ramassamy C
J Alzheimers Dis; 2010; 21(1):229-47. PubMed ID: 20421692
[TBL] [Abstract][Full Text] [Related]
4. Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.
Abdul HM; Calabrese V; Calvani M; Butterfield DA
J Neurosci Res; 2006 Aug; 84(2):398-408. PubMed ID: 16634066
[TBL] [Abstract][Full Text] [Related]
5. Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease.
Williams TI; Lynn BC; Markesbery WR; Lovell MA
Neurobiol Aging; 2006 Aug; 27(8):1094-9. PubMed ID: 15993986
[TBL] [Abstract][Full Text] [Related]
6. Molecular regulations induced by acrolein in neuroblastoma SK-N-SH cells: relevance to Alzheimer's disease.
Dang TN; Arseneault M; Zarkovic N; Waeg G; Ramassamy C
J Alzheimers Dis; 2010; 21(4):1197-216. PubMed ID: 21504135
[TBL] [Abstract][Full Text] [Related]
7. Modulation of phospholipid asymmetry in synaptosomal membranes by the lipid peroxidation products, 4-hydroxynonenal and acrolein: implications for Alzheimer's disease.
Castegna A; Lauderback CM; Mohmmad-Abdul H; Butterfield DA
Brain Res; 2004 Apr; 1004(1-2):193-7. PubMed ID: 15033435
[TBL] [Abstract][Full Text] [Related]
8. Acrolein induces Alzheimer's disease-like pathologies in vitro and in vivo.
Huang YJ; Jin MH; Pi RB; Zhang JJ; Ouyang Y; Chao XJ; Chen MH; Liu PQ; Yu JC; Ramassamy C; Dou J; Chen XH; Jiang YM; Qin J
Toxicol Lett; 2013 Mar; 217(3):184-91. PubMed ID: 23296102
[TBL] [Abstract][Full Text] [Related]
9. Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures.
Lovell MA; Xie C; Markesbery WR
Free Radic Biol Med; 2000 Oct; 29(8):714-20. PubMed ID: 11053772
[TBL] [Abstract][Full Text] [Related]
10. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease.
Marcus DL; Thomas C; Rodriguez C; Simberkoff K; Tsai JS; Strafaci JA; Freedman ML
Exp Neurol; 1998 Mar; 150(1):40-4. PubMed ID: 9514828
[TBL] [Abstract][Full Text] [Related]
11. Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease.
Calingasan NY; Uchida K; Gibson GE
J Neurochem; 1999 Feb; 72(2):751-6. PubMed ID: 9930749
[TBL] [Abstract][Full Text] [Related]
12. Cysteine modification by lipid peroxidation products inhibits protein disulfide isomerase.
Carbone DL; Doorn JA; Kiebler Z; Petersen DR
Chem Res Toxicol; 2005 Aug; 18(8):1324-31. PubMed ID: 16097806
[TBL] [Abstract][Full Text] [Related]
13. Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures.
Lovell MA; Xie C; Markesbery WR
Neurobiol Aging; 2001; 22(2):187-94. PubMed ID: 11182468
[TBL] [Abstract][Full Text] [Related]
14. Development of a method for quantification of acrolein-deoxyguanosine adducts in DNA using isotope dilution-capillary LC/MS/MS and its application to human brain tissue.
Liu X; Lovell MA; Lynn BC
Anal Chem; 2005 Sep; 77(18):5982-9. PubMed ID: 16159131
[TBL] [Abstract][Full Text] [Related]
15. Regulation of redox-sensitive signaling pathways in rat primary astrocytes following acrolein exposure.
Dang TN; Arseneault M; Ramassamy C
J Alzheimers Dis; 2011; 25(2):263-77. PubMed ID: 21422526
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of 4-hydroxy-2-nonenal and acrolein toxicity: nucleophilic targets and adduct formation.
LoPachin RM; Gavin T; Petersen DR; Barber DS
Chem Res Toxicol; 2009 Sep; 22(9):1499-508. PubMed ID: 19610654
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis of rat cerebral cortex following subchronic acrolein toxicity.
Rashedinia M; Lari P; Abnous K; Hosseinzadeh H
Toxicol Appl Pharmacol; 2013 Oct; 272(1):199-207. PubMed ID: 23743302
[TBL] [Abstract][Full Text] [Related]
18. Increased brain levels of 4-hydroxy-2-nonenal glutathione conjugates in severe Alzheimer's disease.
Völkel W; Sicilia T; Pähler A; Gsell W; Tatschner T; Jellinger K; Leblhuber F; Riederer P; Lutz WK; Götz ME
Neurochem Int; 2006 Jun; 48(8):679-86. PubMed ID: 16483694
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of c-jun and CREB by acrolein and 4-hydroxynonenal.
Pugazhenthi S; Phansalkar K; Audesirk G; West A; Cabell L
Free Radic Biol Med; 2006 Jan; 40(1):21-34. PubMed ID: 16337876
[TBL] [Abstract][Full Text] [Related]
20. Oxidatively modified GST and MRP1 in Alzheimer's disease brain: implications for accumulation of reactive lipid peroxidation products.
Sultana R; Butterfield DA
Neurochem Res; 2004 Dec; 29(12):2215-20. PubMed ID: 15672542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
